PFM Health Sciences, LP - Q4 2019 holdings

$2.1 Billion is the total value of PFM Health Sciences, LP's 61 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 81.9% .

 Value Shares↓ Weighting
GILD NewGILEAD SCIENCES INCcall$196,513,0003,024,200
+100.0%
9.36%
ALXN SellALEXION PHARMACEUTICALS INC$116,417,000
-17.8%
1,076,442
-25.6%
5.54%
+32.5%
CI NewCIGNA CORP NEWcall$106,233,000519,500
+100.0%
5.06%
GILD SellGILEAD SCIENCES INC$87,836,000
-24.8%
1,351,736
-26.7%
4.18%
+21.2%
BOLD SellAUDENTES THERAPEUTICS INC$73,775,000
+13.4%
1,232,873
-46.8%
3.51%
+82.9%
PEN SellPENUMBRA INC$68,795,000
-50.3%
418,792
-59.3%
3.28%
-19.9%
NVRO BuyNEVRO CORP$67,840,000
+99.1%
577,163
+45.6%
3.23%
+221.2%
BIIB NewBIOGEN INC$67,752,000228,328
+100.0%
3.23%
ZBH SellZIMMER BIOMET HLDGS INC$66,252,000
-51.1%
442,627
-55.2%
3.16%
-21.2%
ANTM NewANTHEM INC$59,967,000198,548
+100.0%
2.86%
AERI BuyAERIE PHARMACEUTICALS INC$58,333,000
+65.8%
2,413,464
+31.8%
2.78%
+167.4%
CI SellCIGNA CORP NEW$54,336,000
-10.0%
265,717
-33.2%
2.59%
+45.1%
AGN SellALLERGAN PLC$53,824,000
-29.8%
281,548
-38.2%
2.56%
+13.3%
IQV SellIQVIA HLDGS INC$53,085,000
-25.5%
343,567
-28.0%
2.53%
+20.2%
CNC NewCENTENE CORP DEL$51,505,000819,229
+100.0%
2.45%
ARNA SellARENA PHARMACEUTICALS INC$48,627,000
-53.2%
1,070,616
-52.9%
2.32%
-24.6%
BMRN SellBIOMARIN PHARMACEUTICAL INC$46,810,000
-67.7%
553,634
-74.2%
2.23%
-47.9%
KRTX BuyKARUNA THERAPEUTICS INC$45,396,000
+577.4%
602,551
+46.7%
2.16%
+991.9%
HCA SellHCA HEALTHCARE INC$41,300,000
-17.7%
279,411
-33.0%
1.97%
+32.7%
NVS SellNOVARTIS A Gsponsored adr$40,679,000
-31.8%
442,640
-35.8%
1.94%
+10.0%
PFE NewPFIZER INC$36,168,000923,126
+100.0%
1.72%
DERM SellDERMIRA INC$34,431,000
+40.7%
2,271,180
-40.7%
1.64%
+126.8%
ICLR SellICON PLC$33,340,000
-4.6%
193,577
-18.4%
1.59%
+53.9%
IMMU NewIMMUNOMEDICS INC$31,724,0001,499,239
+100.0%
1.51%
IRTC SellIRHYTHM TECHNOLOGIES INC$31,202,000
-61.1%
458,241
-57.6%
1.49%
-37.2%
ICUI NewICU MED INC$30,999,000165,665
+100.0%
1.48%
HUM NewHUMANA INC$29,155,00079,546
+100.0%
1.39%
 DERMIRA INCnote 3.000% 5/1$28,270,000
+10.5%
30,558,0000.0%1.35%
+78.2%
ABT NewABBOTT LABS$28,031,000322,713
+100.0%
1.34%
UNH NewUNITEDHEALTH GROUP INC$27,840,00094,699
+100.0%
1.33%
VRTX NewVERTEX PHARMACEUTICALS INCcall$27,631,000126,200
+100.0%
1.32%
BPMC NewBLUEPRINT MEDICINES CORPput$26,981,000336,800
+100.0%
1.28%
NVST NewENVISTA HLDGS CORP$24,475,000825,732
+100.0%
1.17%
EW SellEDWARDS LIFESCIENCES CORP$24,094,000
-56.5%
103,279
-59.0%
1.15%
-29.8%
MOH SellMOLINA HEALTHCARE INC$24,012,000
-55.5%
176,964
-64.0%
1.14%
-28.2%
NewBIOMARIN PHARMACEUTICAL INCnote 1.500%10/1$19,842,00018,275,000
+100.0%
0.94%
EXAS NewEXACT SCIENCES CORP$19,406,000209,839
+100.0%
0.92%
CTLT SellCATALENT INC$17,845,000
-66.2%
316,962
-71.4%
0.85%
-45.4%
NewMORPHOSYS AGsponsored ads$15,504,000122,275
+100.0%
0.74%
AXNX BuyAXONICS MODULATION TECH INC$15,241,000
+125.2%
550,026
+118.7%
0.73%
+263.0%
ABBV NewABBVIE INC$14,719,000166,239
+100.0%
0.70%
CSII SellCARDIOVASCULAR SYS INC DEL$13,347,000
-39.6%
274,689
-40.9%
0.64%
-2.6%
VRTX NewVERTEX PHARMACEUTICALS INC$12,463,00056,922
+100.0%
0.59%
AMRN NewAMARIN CORP PLCspons adr new$11,437,000533,421
+100.0%
0.54%
FLDM BuyFLUIDIGM CORP DEL$11,258,000
-21.8%
3,234,984
+4.0%
0.54%
+26.1%
MSFT SellMICROSOFT CORP$11,255,000
-67.7%
71,367
-71.5%
0.54%
-47.9%
HALO NewHALOZYME THERAPEUTICS INC$10,522,000593,480
+100.0%
0.50%
CRM SellSALESFORCE COM INC$10,311,000
-80.2%
63,398
-81.9%
0.49%
-68.0%
CHRS SellCOHERUS BIOSCIENCES INC$9,634,000
-31.1%
535,086
-22.4%
0.46%
+11.1%
BABA SellALIBABA GROUP HLDG LTDsponsored ads$9,420,000
-30.6%
44,411
-45.3%
0.45%
+12.0%
NVDA NewNVIDIA CORP$9,386,00039,889
+100.0%
0.45%
BIIB NewBIOGEN INCcall$8,991,00030,300
+100.0%
0.43%
MCHP SellMICROCHIP TECHNOLOGY INC$8,553,000
-88.9%
81,671
-90.2%
0.41%
-82.1%
NXPI SellNXP SEMICONDUCTORS N V$7,922,000
-89.8%
62,249
-91.2%
0.38%
-83.5%
SQ NewSQUARE INCcl a$5,032,00080,427
+100.0%
0.24%
INTU SellINTUIT$4,387,000
-90.8%
16,747
-90.7%
0.21%
-85.2%
ACOR SellACORDA THERAPEUTICS INC$3,863,000
-38.4%
1,893,400
-13.4%
0.18%
-0.5%
PYPL BuyPAYPAL HLDGS INC$2,063,000
+30.7%
19,076
+25.2%
0.10%
+108.5%
VC SellVISTEON CORP$1,759,000
-85.8%
20,313
-86.4%
0.08%
-77.0%
COUP SellCOUPA SOFTWARE INC$1,423,000
-93.4%
9,731
-94.2%
0.07%
-89.4%
ELGXQ SellENDOLOGIX INC$252,000
-75.0%
159,285
-37.3%
0.01%
-60.0%
AMK ExitASSETMARK FINL HLDGS INC$0-29,259
-100.0%
-0.02%
LVGO ExitLIVONGO HEALTH INC$0-106,380
-100.0%
-0.06%
ALNA ExitALLENA PHARMACEUTICALS INC$0-486,978
-100.0%
-0.06%
TW ExitTRADEWEB MKTS INCcl a$0-67,157
-100.0%
-0.07%
EQ ExitEQUILLIUM INC$0-1,064,979
-100.0%
-0.12%
EIDX ExitEIDOS THERAPEUTICS INC$0-126,181
-100.0%
-0.13%
DLPH ExitDELPHI TECHNOLOGIES PLC$0-429,452
-100.0%
-0.17%
GS ExitGOLDMAN SACHS GROUP INC$0-47,320
-100.0%
-0.29%
AVRO ExitAVROBIO INC$0-783,975
-100.0%
-0.33%
LYV ExitLIVE NATION ENTERTAINMENT IN$0-197,341
-100.0%
-0.39%
FATE ExitFATE THERAPEUTICS INC$0-881,002
-100.0%
-0.40%
PRNB ExitPRINCIPIA BIOPHARMA INC$0-559,553
-100.0%
-0.47%
TWTR ExitTWITTER INC$0-477,780
-100.0%
-0.58%
ExitPTC THERAPEUTICS INCnote 3.000% 8/1$0-19,807,000
-100.0%
-0.61%
VYGR ExitVOYAGER THERAPEUTICS INC$0-1,231,954
-100.0%
-0.63%
INSP ExitINSPIRE MED SYS INC$0-350,870
-100.0%
-0.63%
MCK ExitMCKESSON CORPcall$0-167,400
-100.0%
-0.68%
V ExitVISA INC$0-134,188
-100.0%
-0.68%
AMD ExitADVANCED MICRO DEVICES INC$0-890,079
-100.0%
-0.76%
MKSI ExitMKS INSTRUMENT INC$0-301,611
-100.0%
-0.82%
MRTX ExitMIRATI THERAPEUTICS INC$0-431,123
-100.0%
-0.99%
ExitACORDA THERAPEUTICS INCnote 1.750% 6/1$0-49,764,825
-100.0%
-1.16%
PBYI ExitPUMA BIOTECHNOLOGY INC$0-3,689,538
-100.0%
-1.17%
SYK ExitSTRYKER CORP$0-207,887
-100.0%
-1.33%
QURE ExitUNIQURE NV$0-1,158,694
-100.0%
-1.35%
WDC ExitWESTERN DIGITAL CORP$0-795,919
-100.0%
-1.40%
GDDY ExitGODADDY INCcl a$0-723,756
-100.0%
-1.41%
SAGE ExitSAGE THERAPEUTICS INC$0-373,828
-100.0%
-1.55%
PTCT ExitPTC THERAPEUTICS INC$0-1,654,225
-100.0%
-1.65%
TWLO ExitTWILIO INCcl a$0-534,889
-100.0%
-1.74%
DXCM ExitDEXCOM INC$0-428,242
-100.0%
-1.89%
MYOK ExitMYOKARDIA INC$0-1,227,371
-100.0%
-1.89%
WCG ExitWELLCARE HEALTH PLANS INC$0-263,626
-100.0%
-2.02%
XBI ExitSPDR SERIES TRUSTput$0-1,143,600
-100.0%
-2.58%
ExitNOVO-NORDISK A Sadr$0-1,133,574
-100.0%
-11.79%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-02-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MOLINA HEALTHCARE INC41Q3 20232.2%
HCA HOLDINGS INC38Q3 20235.2%
HUMANA INC37Q3 20233.8%
EDWARDS LIFESCIENCES CORP36Q3 20233.3%
UNITEDHEALTH GROUP INC33Q3 20234.8%
PENUMBRA INC33Q3 20234.8%
AERIE PHARMACEUTICALS INC28Q2 20223.7%
TENET HEALTHCARE CORP27Q3 20232.3%
ELEVANCE HEALTH INC26Q3 20234.2%
ICON PLC26Q3 20232.5%

View PFM Health Sciences, LP's complete holdings history.

Latest significant ownerships (13-D/G)

View PFM Health Sciences, LP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
SC 13G2023-04-21

View PFM Health Sciences, LP's complete filings history.

Compare quarters

Export PFM Health Sciences, LP's holdings